ARHGDIA

ARHGDIA

Target · Rho GTPase regulator

ARHGDIA Rho GDP dissociation inhibitor alpha · Rho GDP-dissociation inhibitor 1

ARHGDIA (Rho GDP dissociation inhibitor alpha, also known as RHOGDI or GDIA1) is a cytoplasmic regulator of Rho family GTPases. It holds Rho proteins in an inactive state by inhibiting the release of GDP, and so helps control Rho signalling. Browse Assay Genie's current range of ARHGDIA research reagents below, or read on for the biology behind the target.

Cytoplasmic proteinRho GDP dissociation inhibitorLinked to nephrotic syndrome
204 aa
Protein length
~23 kDa
Molecular weight
17q25.3
Gene locus
Rho GDI family
Protein family
Target information

What is ARHGDIA (rho GDP dissociation inhibitor alpha)?

ARHGDIA controls Rho protein homeostasis. It regulates the GDP/GTP exchange reaction of Rho proteins by inhibiting the dissociation of GDP from them, which in turn prevents the subsequent binding of GTP. In this way it keeps Rho proteins such as CDC42, RAC1 and RHOA in an inactive cytosolic pool, where it regulates their stability and protects them from degradation.

The protein also takes part in the recycling and distribution of activated Rho GTPases within the cell. It extracts both inactive and activated molecules from membranes, owing to its exceptionally high affinity for their prenylated forms. Through this modulation of Rho proteins, ARHGDIA may play a role in regulating cell motility. In glioma cells, it inhibits migration and invasion by mediating signals from SEMA5A and PLXNB3 that lead to inactivation of RAC1.

The ARHGDIA gene belongs to the Rho GDI family and encodes the protein listed in UniProt as Rho GDP-dissociation inhibitor 1. Its previous name was Rho GDP dissociation inhibitor (GDI) alpha. According to the NCBI Gene summary, its activity matters in a variety of cellular processes, and expression of the gene may be altered in tumours. Mutations in the gene have been found in individuals with nephrotic syndrome, type 8, and alternate splicing produces multiple transcript variants. Mouse and rat both carry an orthologous gene, Arhgdia, which allows the pathway to be studied in rodent models.

Rho GTPase signalling

ARHGDIA inhibits GDP release from Rho proteins and keeps them inactive, making it a central regulator of Rho family signalling.

Cell motility and invasion

Through Rho protein modulation it may regulate cell motility, and in glioma cells it inhibits migration and invasion via RAC1 inactivation.

Cancer biology

Expression of the ARHGDIA gene may be altered in tumours, so the protein is of interest in studies of tumour cell behaviour.

Nephrotic syndrome research

Mutations in ARHGDIA have been found in individuals with nephrotic syndrome, type 8, linking the gene to kidney disease studies.

Background

ARHGDIA frequently asked questions

What does ARHGDIA do?

ARHGDIA inhibits the dissociation of GDP from Rho proteins and the subsequent binding of GTP, holding proteins such as CDC42, RAC1 and RHOA in an inactive cytosolic pool. It also protects them from degradation and helps extract prenylated Rho GTPases from membranes.

What other names does ARHGDIA go by?

ARHGDIA is also called RHOGDI and GDIA1. The HGNC name is Rho GDP dissociation inhibitor alpha, previously Rho GDP dissociation inhibitor (GDI) alpha, and UniProt lists the protein as Rho GDP-dissociation inhibitor 1. Alternate splicing gives multiple transcript variants.

Is ARHGDIA linked to disease?

Mutations in the ARHGDIA gene have been found in individuals with nephrotic syndrome, type 8, and its expression may be altered in tumours. Mouse and rat share an orthologous Arhgdia gene; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Rho GTPases, other Rho GDI family members and signalling partners that act alongside ARHGDIA.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P52565; product specifications from Assay Genie datasheets.

ARHGDIA Product listing